ニュース

Zepbound trims more belly fat than Wegovy, study shows
The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...
RFK Jr. aide: GLP-1 weight loss meds will cost the same as in least expensive countries
Aide to RFK Jr. says White House is pushing for global price parity on GLP-1 drugs for weight loss. Read more here.
Zacks Investment Research on MSN1 日
Lilly Down 17% Since Q1 Results: Should You Buy the Dip in LLY Stock?
Eli Lilly and Company’s LLY shares have lost 17% so far in May. Lilly announced mixed earnings results on May 1. It missed ...
Lilly’s Zepbound Trims More Belly Fat Than Novo’s Wegovy
Eli Lilly & Co.’s obesity drug Zepbound helped people trim about two inches more off their waists than Novo Nordisk A/S’s ...
Los Angeles Daily News3 日
Zepbound trims more belly fat than Wegovy, study shows
Although Novo was first to market with Wegovy and its sister ... The company is also studying Zepbound’s impact on illness and death in a trial that’s due to deliver results in 2027.
Beyond Valuation Ratios: 3 Undervalued Stocks To Buy In May 2025
Looking for undervalued stocks? Check out three top undervalued stocks to buy now in May, 2025 to boost your portfolio.